{
  "docId": "019de074-ead2-732b-8415-93449fe93e32",
  "docSlug": "9cc66a7a8f583a45c6978147aa12db97",
  "documentTitle": "Freeman Capital Management | Activist Presentation Deck | 95 slides",
  "authorId": "freeman-capital-management",
  "authorName": "Freeman Capital Management",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 67,
  "pageCount": 95,
  "prevPage": 66,
  "nextPage": 68,
  "slideType": "timeline",
  "function": "plan_implementation",
  "density": "sparse",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de074-ead2-732b-8415-93449fe93e32/67",
  "deckHref": "/decks/019de074-ead2-732b-8415-93449fe93e32",
  "deckJsonHref": "/decks/019de074-ead2-732b-8415-93449fe93e32.json",
  "deckAnchorHref": "/decks/019de074-ead2-732b-8415-93449fe93e32#slide-67",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.139,
        "x": 0.113,
        "y": 0.317
      },
      "kind": "diagram",
      "text": "Sep 2023 to Dec 2023",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "30c755a5-932f-4eb8-8828-662dab94dd10",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.105,
        "w": 0.415,
        "x": 0.271,
        "y": 0.418
      },
      "kind": "list",
      "text": "Review timeline for: Performing pre-clinical safety studies, Extending Phase I to get a 30-day dose, and the timing for NDA.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4b1e8ce2-9264-4f49-a188-13ae5cbdd64a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.024,
        "w": 0.445,
        "x": 0.271,
        "y": 0.335
      },
      "kind": "paragraph",
      "text": "Review of MM-110 data in Phase I study (Low Priority)",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "28e1a8ab-0d2c-436c-9502-58d63af4be05",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.055,
        "w": 0.415,
        "x": 0.271,
        "y": 0.645
      },
      "kind": "paragraph",
      "text": "Commercial analysis of market opportunities in opioid addiction treatment.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6d0a5a88-7e92-413b-831e-b24e7a99c9a3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.067,
        "w": 0.43,
        "x": 0.047,
        "y": 0.056
      },
      "kind": "title",
      "text": "MM-110 Preclinical Safety Studies",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7d7e8fde-fefc-4330-8fa7-f27324b9e0d6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "39f5d7fa-d717-47b3-ba85-c77457c61420",
      "evidence": "Timeline representation of project tasks",
      "confidence": 0.6
    }
  ],
  "arcBeats": [
    {
      "to": 95,
      "from": 61,
      "beatId": "383f2f65-7b68-449f-b311-9bc0591c8aab",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The document presents Freeman Capital Management's plan to restore value in Mind Medicine, including bringing MM-120 to market quickly and safely, and aligning G&A and headcount.",
      "position": 2,
      "confidence": 0.9,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 70,
      "from": 62,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "86491bd2-85cc-4539-897c-03a8ac16c31c",
      "evidence": "The document presents Freeman Capital Management's plan to bring MM-120 to market quickly and safely, and to align G&A and headcount.",
      "position": 1,
      "objective": "What are the quick wins and big bets that Freeman Capital Management can make to restore value in Mind Medicine?",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.7,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}